A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza

NCT02603952 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Oseltamivir
DRUG: MEDI8852
DRUG: Placebo

Sponsor

MedImmune LLC